期刊
CURRENT DRUG METABOLISM
卷 14, 期 4, 页码 504-515出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389200211314040012
关键词
Polyphenol; drug delivery; nanomedicine; cancer therapeutics; bioavailability; protein corona
资金
- National Institutes of Health [CA142736]
- Centers of Biomedical Research Excellence [P20 GM103548-02]
Curcumin, a natural bioactive polyphenol, has been widely investigated as a conventional medicine for centuries. Over the past two decades, major pre-clinical and clinical trials have demonstrated its safe therapeutic profile but clinical translation has been hampered due to rapid degradation, poor water solubility, bioavailability and pharmaco-kinetics. To overcome such translational issues, many laboratories have focused on developing curcumin nanoformulations for cancer therapeutics. In this review, we discuss the evolution of curcumin nanomedicine in cancer therapeutics, the possible interactions between the surface of curcumin nanoparticles and plasma proteins, the role of nanoparticle-protein complex architecture parameters, and the rational design of clinically useful curcumin nanoformulations. Considering all the biologically relevant phenomena, curcumin nanoformulations can be developed as a new neutraceutical or pharmaceutical agent.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据